Voltarol Back & Muscle Pain Relief gel

Voltarol: A Global Leader in Topical Pain Relief

Voltarol, known internationally as Voltaren in many markets, is one of the most recognized names in over-the-counter pain management. Its primary active ingredient, diclofenac, was originally developed in the mid-20th century. The brand has built a significant reputation for providing targeted relief for muscle and joint pain, specifically through its topical gel formulations which are designed to penetrate the skin to treat inflammation directly at the source.

Ownership and Manufacturing Legacy

Originally a creation of the Swiss pharmaceutical giant Ciba-Geigy (which later merged to form Novartis), the Voltarol brand underwent a major corporate transition. In 2015, a joint venture was established between Novartis and GSK (GlaxoSmithKline). This eventually led to the brand becoming a cornerstone of Haleon, a dedicated consumer healthcare company spun off from GSK and Novartis in 2022. Today, Haleon is the ultimate owner of the brand, continuing its legacy of pharmaceutical excellence.

Production and Distribution

While the brand has its roots in Switzerland and maintains a strong corporate presence in the United Kingdom, manufacturing of Voltarol products occurs in multiple countries across Europe and North America to meet global demand. Common production sites include facilities in Germany and Switzerland, ensuring that the high standards of pharmaceutical production are maintained while facilitating efficient delivery to international markets.